CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes (TN-18)

Enroll Now

Type of Study:

Type 1 Diabetes

Title of Study:

CTLA4-Ig (Abatacept) for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes (TN-18)

Study Length: Indefinite

Target Age/Sex: Any

Link: ClinicalTrials.gov